Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Current Medicinal Chemistry|November 18, 2011
Effects of BCR-ABL inhibitors on anti-tumor immunityM Krusch, H R Salih
European Journal of Medical Research|September 11, 2001
Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?H R Salih, V Nüssler
Praxis|March 23, 2005
[Neuro-endocrine tumors of the gastrointestinal tract: epidemiology, classification, prognosis, diagnosis and therapeutic modalities]H R Salih, J T Hartmann
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Simultaneous cytofluorometric measurement of phagocytosis, burst production and killing of human phagocytes using Candida albicans and Staphylococcus aureus as target organismsH R Salih, L Husfeld, D Adam
International Journal of Clinical Pharmacology and Therapeutics|December 7, 2002
4-1 BB ligand--just another costimulating molecule?H R Salih, P A Kiener, V Nüssler
Leukemia|November 9, 2011
Glucocorticoid-induced TNFR-related protein (GITR) ligand modulates cytokine release and NK cell reactivity in chronic lymphocytic leukemia (CLL)C Buechele, T Baessler, S Wirths, et al.
European Journal of Haematology|June 28, 2006
Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphomaN Hentschel, M Krusch, P A Kiener, et al.
Leukemia|February 25, 2015
Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysisJ Wild, B J Schmiedel, A Maurer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2001
Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignanciesH R Salih, H M Schmetzer, C Burke, et al.
Experimental Cell Research|October 20, 2001
Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: consequences for induction of apoptosis in CD95-sensitive cellsH R Salih, G C Starling, M Knauff, et al.
Pageof 3